Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-ß-lactamase Inhibitors.
ACS Med Chem Lett
; 9(4): 359-364, 2018 Apr 12.
Article
de En
| MEDLINE
| ID: mdl-29670701
ABSTRACT
A series of rhodanines was constructed, their Z-configuration was confirmed by small molecule X-ray crystal structures, and their activity against metallo-ß-lactamases (MßLs) was measured. The obtained 26 molecules and a thioenolate specifically inhibited the MßL L1 with an IC50 range of 0.02-1.7 µM, and compounds 2h-m exhibited broad-spectrum inhibition of the MßLs NDM-1, VIM-2, ImiS, and L1 with IC50 values <16 µM. All inhibitors increased the antimicrobial effect of cefazolin against E. coli cells expressing L1, resulting in a 2-8-fold reduction in MIC. Docking studies suggested that the nitro (NDM-1, CphA, and L1) or carboxyl group (VIM-2) of 2l coordinates one or two Zn(II) ions, while the N-phenyl group of the inhibitor enhances its hydrophobic interaction with MßLs. These studies demonstrate that the diaryl-substituted rhodanines are good scaffolds for the design of future broad-spectrum inhibitors of MßLs.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
ACS Med Chem Lett
Année:
2018
Type de document:
Article